InfuSystem Holdings INFU Device Solutions — Depreciation and amortization of intangible assets

Other segment segments

Similar metrics at other companies

ITRIDevice Solutions — Depreciation and amortization of intangible assets

$2.2M+4.7%

NOVTMedical Solutions — Intangible Amortization

$3.66M+16.2%

ASSTMedical Device — D&A

$32K—

XRXIT Solutions — D&A

$1M—

CSPITechnology Solutions — D&A

$51K+24.4%

MCKMedical-Surgical Solutions — Total segment depreciation and amortization

$25M+4.2%

Questions, answered.

What is InfuSystem Holdings's device solutions — depreciation and amortization of intangible assets?

InfuSystem Holdings (INFU) reported device solutions — depreciation and amortization of intangible assets of $1.21M in Q1 2026.

How has InfuSystem Holdings's device solutions — depreciation and amortization of intangible assets changed year-over-year?

InfuSystem Holdings's device solutions — depreciation and amortization of intangible assets decreased by 2.2% year-over-year, from $1.24M to $1.21M.

What is the long-term trend for InfuSystem Holdings's device solutions — depreciation and amortization of intangible assets?

Over 4 years (2021 to 2025), InfuSystem Holdings's device solutions — depreciation and amortization of intangible assets has grown at a 6.5% compound annual growth rate (CAGR), from $3.74M to $4.8M.

What does device solutions — depreciation and amortization of intangible assets mean?

The non-cash expense recognized over the useful life of tangible medical equipment and intangible assets assigned to the Device Solutions segment. This metric accounts for the wear and tear of the device fleet and the consumption of acquired intangible value. It is a key component in reconciling net income to cash flow and understanding the true economic cost of maintaining the segment's asset base.